Redirect Notice
The previous page is sending you to
https://www.farmaindustria.es/web/otra-noticia/estamos-ante-una-oportunidad-unica-para-evitar-reevaluaciones-innecesarias-de-medicamentos-que-estan-retrasando-el-acceso-de-los-pacientes-a-la-innovacion/
.
If you do not want to visit that page, you can
return to the previous page
.